Sage Journals: Discover world-class research

Free access

Review article

First published 2017-5

The efficacy of evolocumab in the management of hyperlipidemia: a systematic review

Lamia AlHajri, Asma AlHadhrami, Shama AlMheiri [...]

Therapeutic Advances in Cardiovascular Disease

Free access

Research article

First published 2018-9

Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals

Scott M. Wasserman, Marc S. Sabatine, Michael J. Koren [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Research article

First published 2024

Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study

Isabella Sudano, Stephan Krähenbühl, François Mach [...]

Therapeutic Advances in Cardiovascular Disease

Retricted access

Review article

First published 2015-12

Therapeutic Potential and Critical Analysis of the PCSK9 Monoclonal Antibodies Evolocumab and Alirocumab

C. Michael White

Annals of Pharmacotherapy

Retricted access

Research article

First published 2020

LDL-cholesterol lowering with evolocumab,and outcomes according to age and sex in patients in the FOURIER Trial

Peter Sever, Ioanna Gouni-Berthold, Anthony Keech [...]

European Journal of Preventive Cardiology

Open access

Research article

First published 2023

Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study

Vladimír Blaha, Roman Margoczy, Ivo Petrov [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Research article

First published 2020

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial

Ikaro Breder, Jessica Cunha Breder, Isabella Bonilha [...]

Sage Open Chronic Disease

Retricted access

Research article

First published 2024-10

PCSK9 Inhibitor with Statin Therapy for Intracranial Artery Stenosis ( PISTIAS): Rationale and design of a multicenter randomized controlled trial

Xinzhi Hu, Zongmuyu Zhang, Caiyan Liu [...]

International Journal of Stroke

Open access

Research article

First published 2021

Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in Apc Min/+ mice

Kai Yang, Jie Zhu, Huan-hua Luo [...]

International Journal of Immunopathology and Pharmacology

Retricted access

Research article

First published 2017-6

Evolocumab and clinical outcomes in patients with cardiovascular disease

S Hadjiphilippou, KK Ray

Journal of the Royal College of Physicians of Edinburgh

Search results